Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 7Osteosarcoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma 6Testicular Neoplasms 4Burkitt Lymphoma 4Testicular Germ Cell Tumor 3Teratoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Lymphoma, B-Cell 3Carcinoma, Renal Cell 3Breast Neoplasms 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Ovarian Neoplasms 2Optic Nerve Glioma 2Neuroblastoma 2Neoplasms 2Medulloblastoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphatic Diseases 2Liver Neoplasms 2Kidney Neoplasms 2Immunoproliferative Disorders 2Hematologic Diseases 2Fibrosarcoma 2Familial ependymoma 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

pazopanib 2Trabectedin 2Doxorubicin 2sapanisertib 1rucaparib 1pembrolizumab 1itacitinib 1baricitinib 1avelumab 1Vorinostat 1TTI-621 1PTC596 1Letrozole 1Ifosfamide 1INCB039110 1Docetaxel 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leiomyosarcoma × Ifosfamide × Clear all
NCT00003292 2013-11-08

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

SWOG Cancer Research Network

Phase 2 Terminated
7 enrolled
CNSSarcoma

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Meningioma, Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡